Core Viewpoint - Norwegian Cruise Line Holdings Ltd. (NCLH) is experiencing stock performance challenges despite its significant market capitalization of $9.1 billion, with recent trends indicating underperformance compared to industry peers and broader market indices [1][2][5]. Company Overview - NCLH operates as a cruise company in North America and internationally, offering services under the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands [1]. - The company is classified as a mid-cap stock, with a market capitalization comfortably between $2 billion and $10 billion, reflecting its scale and market presence [2]. Stock Performance - The stock reached a 52-week high of $27.18 on September 12, 2025, but has since declined by 27.3% from that peak [3]. - Over the past three months, NCLH shares have decreased by 14.7%, underperforming the State Street Consumer Discretionary Select Sector SPDR ETF (XLY), which declined by 10.6% during the same period [3]. - In the last 52 weeks, NCLH shares have fallen by 4.5%, while XLY has increased by 7.3%, indicating a significant lag in performance [5]. Market Dynamics - NCLH has been trading below its 200-day and 50-day moving averages, indicating short-term bearish momentum [5]. - A recent announcement regarding a ceasefire in the Middle East led to a more than 9% increase in NCLH shares, driven by a decline in fuel costs as crude oil prices dropped over 10% [7]. Competitive Position - Compared to its peer Royal Caribbean Cruises Ltd. (RCL), NCLH has underperformed, with RCL's stock surging 22% over the past 52 weeks [8]. - Wall Street analysts maintain a cautious optimism regarding NCLH, with a consensus rating of "Moderate Buy" among 23 analysts and a mean price target of $25.95, suggesting a potential upside of 31.9% from current levels [8].

Company Overview - Henry Schein, Inc. (HSIC) has a market cap of $8.5 billion and is a global healthcare distribution and solutions company headquartered in Melville, New York, serving healthcare professionals in over 30 countries [1] - The company is classified as a "mid-cap" stock, valued between $2 billion and $10 billion, and offers an integrated "one-stop-shop" ecosystem that combines a broad distribution network with software, financial services, and consulting [2] Financial Performance - For FY2025 Q4, Henry Schein reported total net sales of $3.4 billion, a year-over-year increase of 7.7%, and a non-GAAP net income growth of 12.6% to $1.34 [6] - Adjusted EBITDA for the quarter rose 7.8% from the previous year to $291 million, with Global Specialty Products sales increasing by 14.6%, driven by strong dental implant and endodontics sales [6] Stock Performance - HSIC shares have retreated 16.6% from their 52-week high of $89.29 and have declined 2.7% over the past three months, while the S&P 500 Index fell by 4.8% during the same period [3] - Over the past six months, HSIC stock has increased by 7.6%, outperforming the S&P 500's 1.1% increase, but has only climbed 7.3% over the past 52 weeks compared to the S&P 500's 16.1% return [5] - The stock has been trading above its 200-day moving average since November 2025 but has recently slipped below its 50-day moving average [5] Competitive Landscape - Rival Quest Diagnostics Incorporated (DGX) has outperformed HSIC stock, returning 4.6% over the past six months and 17.1% over the past 52 weeks [7] - DGX has a consensus rating of "Moderate Buy" from 16 analysts, with a mean price target of $89.78, representing a 20.6% premium to current levels [7]

Company Overview - The Campbell's Company (CPB) is valued at $6.2 billion and is a leading packaged food manufacturer specializing in branded convenience foods, snacks, and meals [1] - CPB has transitioned from a traditional soup maker to a diversified packaged foods player, with snacks now being its primary growth engine [2] Stock Performance - CPB's stock has declined 48.1% from its 52-week high of $40.59 and has fallen 44.5% over the past 52 weeks, significantly underperforming the State Street Consumer Staples Select Sector SPDR Fund (XLP) [3][5] - Over the past three months, CPB stock declined 26.3%, while XLP rose by 3.2% [3] Financial Performance - In FY2026 Q2, CPB reported net sales of $2.56 billion, a 5% decline year over year, and adjusted EPS of $0.51, down 31%, both missing expectations [6] - The decline was attributed to weak volumes in the Snacks segment, unfavorable product mix, input cost inflation, tariffs, and supply chain pressures, leading to margin compression [6] Market Sentiment - Wall Street analysts have a cautious outlook on CPB, with a consensus "Hold" rating from 19 analysts and a mean price target of $24.18, indicating a potential upside of 14.8% from current levels [7]

Company Overview - Pool Corporation (POOL) is the world's largest wholesale distributor of swimming pool and backyard products, operating approximately 455 sales centers across North America, Europe, and Australia, serving nearly 125,000 wholesale customers with over 200,000 products [1] Market Position - The company has a market capitalization of approximately $7.6 billion, classifying it as a mid-cap firm, indicating established business performance with potential for growth [2] Stock Performance - Pool Corporation's stock is currently trading 40.8% below its 52-week high of $345 reached in July, with a decline of 11.9% over the past three months, compared to a 3.3% decline in the S&P 500 Index, indicating greater pressure on POOL stock [3] - Over the past 52 weeks, POOL stock has fallen 36.6%, while the S&P 500 gained 16.4%, showcasing relative underperformance [6] - Year-to-date, the stock is down 10.7%, contrasting with the S&P 500's 3.5% decline, suggesting a continued downward trend into the new year [6] Technical Analysis - The stock has remained below its 50-day moving average of $241.21 since February and below its 200-day moving average of $275.51 since October 2025, reinforcing a sustained downtrend [7] Dividend Announcement - On February 25, Pool Corporation's Board of Directors declared a quarterly cash dividend of $1.25 per share, payable on March 26, which positively impacted the stock, lifting it nearly 4% in the following trading session, indicating that disciplined capital returns can stabilize market sentiment [8] Competitive Comparison - In comparison, rival Applied Industrial Technologies, Inc. (AIT) has gained 11.4% over the past 52 weeks and is only marginally down year-to-date, highlighting a steadier performance relative to Pool Corporation's more significant correction [9]

Company Overview - Builders FirstSource, Inc. (BLDR) is a U.S.-based supplier of building materials and construction services, focusing on new residential construction, repair, and remodeling with a market cap of $9.6 billion [1] - The company offers a variety of products including manufactured components like trusses, wall panels, modular homes, windows, doors, and specialty building materials such as siding, roofing, insulation, and cabinets [1][2] Stock Performance - Shares of Builders FirstSource have declined 42.4% from their 52-week high of $151.03, with a 15.7% decrease over the past three months, underperforming the Nasdaq Composite's 3.2% drop [3] - Year-to-date, BLDR stock has dipped 15.4%, lagging behind the Nasdaq's 3.7% decline, and has fallen 31% over the past 52 weeks compared to the Nasdaq's 26% return [3] - The stock has been trading below its 50-day and 200-day moving averages since mid-September 2025 [4] Financial Performance - In Q4 2025, Builders FirstSource reported a 12.1% year-over-year drop in net sales to $3.4 billion and an 83.4% decline in net income to $31.5 million, with EPS at $0.28 compared to $1.65 a year earlier [5] - Adjusted EBITDA fell 44.3% to $274.9 million, with gross margin declining to 29.8% and EBITDA margin dropping to 8.2% due to a weak housing environment and reduced operating leverage [5] Market Comparison - Rival Trane Technologies plc (TT) has outperformed BLDR stock, gaining 8.3% year-to-date and 21.2% over the past 52 weeks [6] - Despite the weak performance of BLDR, analysts maintain a moderately optimistic outlook, with a consensus rating of "Moderate Buy" and a mean price target of $127.43, representing a 46.4% premium to current levels [6]

Core Insights - The Schwab U.S. Dividend Equity ETF (SCHD) is often compared to the WisdomTree U.S. MidCap Dividend Fund (DON), which has shown competitive long-term performance in a different market segment [2][6]. Group 1: Fund Overview - DON tracks a dividend-weighted index of mid-cap U.S. stocks, distributing dividends to shareholders monthly, with $3.8 billion in assets and a 0.38% expense ratio [3]. - The fund has a 20-year track record, having transitioned to a monthly distribution schedule [3]. Group 2: Dividend Yield and Sector Exposure - DON currently has a 2.4% dividend yield, which is lower than SCHD's 3.62%, indicating that investors choose DON for mid-cap exposure rather than higher yield [4]. - The portfolio is heavily weighted in Financials (22.3%) and Industrials (17.7%), with significant positions in Utilities and Energy, providing diversification across over 300 companies [4]. Group 3: Dividend Stability - DON has maintained uninterrupted monthly distributions for over 19 years, including during the 2008 financial crisis and the 2020 pandemic selloff, with special year-end distributions [5]. Group 4: Performance Comparison - Over five years, DON returned 57.68% compared to SCHD's 59.49%, while over ten years, SCHD outperformed with a 234.05% return versus DON's 153.73% [6][7]. - The recent performance rebound of DON suggests a potential multi-year tailwind as investors rotate into mid-cap stocks, contrasting with high valuations in large-cap stocks [6].

Group 1: Mid Cap Stocks Overview - ProShares UltraPro Short QQQ, Cadence Bank, and Applied Digital are highlighted as key Mid Cap stocks to watch, with a market capitalization typically ranging from $2 billion to $10 billion [2] - Mid-cap stocks are considered a balance between large-cap and small-cap firms, offering more growth potential than large caps while generally presenting less volatility and risk than small caps, making them appealing for moderate-risk, long-term growth strategies [2] Group 2: ProShares UltraPro Short QQQ (SQQQ) - ProShares UltraPro Short QQQ seeks daily investment results that correspond to three times the inverse of the daily performance of the NASDAQ-100 Index, which includes 100 non-financial domestic and international issues listed on the NASDAQ Stock Market [3] Group 3: Cadence Bank (CADE) - Cadence Bank offers a range of commercial banking and financial services, including consumer banking, consumer loans, mortgages, home equity lines and loans, credit cards, and various commercial banking services [3] Group 4: Applied Digital (APLD) - Applied Digital Corporation focuses on designing, developing, and operating datacenters in North America, providing digital infrastructure solutions for the high-performance computing industry, as well as artificial intelligence cloud services and crypto datacenter hosting [4]

What’s the next big stock? On this episode of Market Sense, we’re sitting down with a Fidelity portfolio manager who specializes in spotting opportunities in mid‑cap companies—the potential “sweet spot” of the market. These businesses have often moved beyond the risky startup stage but still have plenty of room to grow, offering a blend of stability and potential upside. We’ll dig into the trends shaping this space, from commercial aerospace and the evolving defense sector to the companies powering the AI b ...

Core Viewpoint - The Federal Reserve's transition from aggressive rate hikes to rate cuts is expected to benefit mid-cap stocks, potentially unlocking gains for companies that have demonstrated resilience in a tighter monetary environment [1][2]. Mid-Cap Growth Stocks - Mid-cap growth stocks are entering a new phase after experiencing one of the most aggressive rate-hike cycles in recent history, with the Fed's rate cuts positioning them to benefit more than other market segments due to their growth characteristics and attractive valuation multiples [2]. - These stocks are considered "long duration" assets, making their valuations sensitive to interest rate changes; as rates decline, the discount rate on future earnings decreases, enhancing stock prices [3]. M&A Activity - Lower borrowing costs are likely to stimulate merger and acquisition (M&A) activity, with mid-cap companies being in a favorable position as they are large enough to attract acquirers but small enough to be manageable targets for larger buyers [4][5]. - The combination of cheaper capital and lower valuations relative to large-cap stocks creates a conducive environment for increased deal activity, as mid-caps have historically been prime acquisition targets during periods of lower rates [5]. Investment Strategy - Not all mid-cap companies will benefit equally; emphasis should be placed on those with high financial quality, solid balance sheets, and strong cash flow generation that have shown resilience during the tightening cycle [6]. - The Alger Mid Cap 40 ETF (FRTY) focuses on approximately 40 holdings selected through fundamental research, targeting companies with proven operating histories and competitive positions rather than speculative firms [7]. AI Adoption Opportunities - While large-cap technology and AI infrastructure investments have garnered significant attention, there are opportunities among mid-sized "AI Adopters" that utilize artificial intelligence to enhance margins or accelerate revenue growth, often overlooked by Wall Street [8]. Market Dynamics - The mid-cap opportunity reflects a historical investor preference for a "barbell" approach, favoring large-cap stocks and small-cap speculation while neglecting mid-caps, which are currently trading at a historically wide discount of 28% based on price-to-earnings ratios as of December 31, 2025 [9].

Core Insights - The article discusses the potential of mid-cap stocks as attractive investment opportunities, particularly in the context of the "America First" agenda which aims to boost domestic manufacturing [2][3]. Industry Overview - The U.S. stock market is experiencing a shift with a growing interest in mid-cap stocks, which are expected to benefit from domestic revenue generation [2]. - Historically, mid-cap equities have outperformed both large-cap and small-cap stocks, although they have lagged behind large caps in the current year [3]. Hedge Fund Activity - Hedge funds are reportedly rotating out of large-cap stocks, with significant reductions in exposure to mega-cap stocks noted in Q3 2025 [4]. - Major hedge funds, such as Bridgewater Associates, have cut holdings in prominent stocks while increasing investments in mid-cap companies [4]. Methodology for Stock Selection - The article outlines a methodology for selecting high-growth mid-cap stocks, focusing on companies with market capitalizations between $2 billion and $10 billion and at least 30% revenue growth over five years [6]. Featured High-Growth Mid-Cap Stocks - **LifeStance Health Group, Inc. (NASDAQ:LFST)** - Market Capitalization: $2.82 billion - Revenue Growth (5Y): 36.75% - Analysts have raised price targets for LFST, indicating a positive outlook despite industry challenges [9][10][11][12]. - **Veracyte, Inc. (NASDAQ:VCYT)** - Market Capitalization: $3.29 billion - Revenue Growth (5Y): 34.46% - The company forecasts sales of $570 million to $582 million in 2026, exceeding consensus estimates [13][14][15]. - **Kinsale Capital Group, Inc. (NYSE:KNSL)** - Market Capitalization: $9.28 billion - Revenue Growth (5Y): 34.25% - Analysts have mixed views, with one firm initiating coverage with an Overweight rating while another lowered its price target due to anticipated near-term declines [16][17][18][19].